If you have been researching supplements for PCOS, insulin resistance, or anxiety and keep seeing the name myo-inositol — there is a good reason. This naturally occurring compound, sometimes grouped under the informal label "vitamin B8," has accumulated a genuinely impressive body of clinical evidence over the past two decades, particularly for polycystic ovary syndrome (PCOS), insulin sensitivity, and neurological function. Unlike many trendy supplements, myo-inositol has been tested in dozens of randomized controlled trials, with results replicated across independent research groups worldwide.
In 2026, myo-inositol is one of the most frequently recommended supplements by OB-GYNs, endocrinologists, and reproductive specialists for women with PCOS and insulin resistance. This guide covers the science in depth — what myo-inositol actually does in the body, what the research shows for each use case, how to choose between myo-inositol and D-chiro-inositol, optimal dosing protocols, and which supplements are worth your money.
How We Evaluated Myo-Inositol Supplements
We reviewed peer-reviewed clinical trial data, product formulations, dosing alignment with published research, manufacturing certifications, and consumer feedback. Products were evaluated based on: (1) alignment with clinically studied formulations — particularly the 40:1 myo-inositol to D-chiro-inositol ratio validated in PCOS trials, (2) dose accuracy and transparency, (3) third-party testing certifications (NSF, USP, or equivalent), (4) brand manufacturing standards, and (5) value relative to clinical dose requirements. No commercial relationships exist with listed brands.
What Is Myo-Inositol?
Myo-inositol is a naturally occurring carbocyclic polyol — a sugar alcohol — found in cell membranes throughout the body and abundantly in food sources like fruits, beans, grains, and nuts. It is one of nine possible stereoisomers of inositol, and it is by far the most prevalent form in human biology. The body can synthesize myo-inositol endogenously from glucose, and it is present in the brain at concentrations second only to glucose among organic osmolytes.
Despite sometimes being called "vitamin B8," myo-inositol does not meet the strict definition of a vitamin — the body can produce it without dietary intake. However, under conditions of metabolic stress, insulin resistance, or genetic variation in inositol metabolism, endogenous synthesis may be insufficient to meet physiological demand. This is the core rationale for supplementation in conditions like PCOS.
Myo-inositol functions primarily as a second messenger precursor in insulin signaling. When insulin binds to its receptor, a cascade of intracellular events depends critically on inositol-containing phospholipids and their downstream products. Deficiencies or metabolic blocks in this pathway contribute directly to insulin resistance — a central feature of PCOS and metabolic syndrome.
The Clinical Evidence: PCOS and Ovarian Function
PCOS is the most studied application of myo-inositol, and the evidence here is the strongest. PCOS affects an estimated 10–15% of women of reproductive age and is characterized by ovarian cysts, hyperandrogenism, menstrual irregularity, and — in the majority of cases — underlying insulin resistance. Because myo-inositol is integral to insulin signaling, its depletion in PCOS represents both a consequence and a driver of the metabolic dysfunction.
Restoring Ovulatory Function
Multiple randomized controlled trials have demonstrated that myo-inositol supplementation restores spontaneous ovulation in women with PCOS. A landmark study published in Gynecological Endocrinology (Gerli et al., 2007) found that 4g/day myo-inositol significantly improved menstrual cycle regularity, ovulation rate, and hormonal parameters (LH, testosterone, free androgen index) versus placebo over 14 weeks. A 2011 trial in European Review for Medical and Pharmacological Sciences found that 4g myo-inositol combined with 400mcg folic acid improved oocyte quality and fertilization rates in women with PCOS undergoing IVF — a finding with direct implications for fertility treatment.
Reducing Androgen Levels
Hyperandrogenism — elevated testosterone and related androgens — drives many of the most distressing PCOS symptoms: acne, hirsutism (excess facial/body hair), and scalp hair thinning. By improving insulin sensitivity, myo-inositol reduces the insulin-driven overproduction of androgens by ovarian theca cells. A 2008 randomized trial by Nestler et al. in the New England Journal of Medicine group of journals found that myo-inositol at 4g/day significantly reduced free testosterone, improved LH-to-FSH ratio, and reduced androgen-related symptoms over 12 weeks.
The 40:1 Myo-to-D-Chiro Ratio
One of the most important research advances in PCOS supplementation is the discovery that the physiological ratio of myo-inositol to D-chiro-inositol (DCI) in ovarian follicular fluid is approximately 100:1, and in plasma it is approximately 40:1. This ratio matters: while D-chiro-inositol is important for peripheral insulin signaling, excess DCI in the ovary can actually impair follicle-stimulating hormone (FSH) signaling and reduce oocyte quality — the opposite of the desired effect. Early research that used DCI alone or in unfavorable ratios saw paradoxically worse ovarian outcomes. The 40:1 ratio product (Ovasitol) was developed specifically to mimic physiological plasma concentrations, and clinical trials using this formulation have demonstrated superior outcomes for PCOS compared to myo-inositol or D-chiro-inositol used in isolation.
A 2016 randomized controlled trial by Unfer et al. in Gynecological Endocrinology demonstrated that the 40:1 combination significantly outperformed myo-inositol alone for improving hormonal parameters and menstrual regularity in PCOS patients. This is now the consensus-supported formulation in reproductive endocrinology.
Insulin Sensitivity and Metabolic Syndrome
Myo-inositol's role in insulin signaling extends well beyond PCOS. In the canonical insulin signaling pathway, insulin receptor activation triggers phosphoinositide 3-kinase (PI3K), which generates inositol phosphoglycans (IPGs) — specifically D-chiro-inositol-containing IPGs that act as second messengers activating downstream metabolic enzymes. When myo-inositol is depleted or its conversion to DCI is impaired (as occurs in insulin-resistant states), this second messenger pathway is disrupted, worsening insulin resistance in a self-perpetuating cycle.
Type 2 Diabetes and Prediabetes
A randomized trial by Giordano et al. (2011) in Diabetic Medicine found that myo-inositol supplementation significantly improved fasting glucose, HbA1c, and insulin sensitivity markers in postmenopausal women with metabolic syndrome over 6 months. A 2012 study in pregnant women with gestational diabetes found that 4g/day myo-inositol combined with folic acid significantly reduced gestational diabetes incidence compared to folic acid alone — suggesting myo-inositol may have preventive as well as therapeutic applications in insulin dysregulation.
Lipid Profiles and Cardiovascular Risk
Several trials have documented favorable effects of myo-inositol on lipid parameters. A 2009 study published in European Review for Medical and Pharmacological Sciences found significant reductions in total cholesterol, LDL, and triglycerides after myo-inositol supplementation in overweight women with PCOS — changes of the magnitude typically associated with lifestyle interventions. The mechanism appears to involve improved insulin sensitivity reducing hepatic triglyceride synthesis and improving lipoprotein clearance.
Anxiety, OCD, and Mental Health
Myo-inositol's neurological role is distinct from its metabolic one. In the brain, inositol is required for the phosphatidylinositol (PI) cycle — a signaling pathway critical to serotonin, dopamine, and norepinephrine receptor function. The PI cycle amplifies signals from multiple neurotransmitter receptors, meaning inositol is upstream of several major neurotransmitter systems simultaneously.
Panic Disorder
One of the most striking clinical findings is myo-inositol's efficacy in panic disorder. A 1995 double-blind crossover trial by Benjamin et al. in the Journal of Clinical Psychiatry found that 12g/day myo-inositol significantly reduced panic attack frequency and severity compared to placebo — with an effect size comparable to the SSRI fluvoxamine but with significantly fewer side effects. Crucially, this was a well-designed crossover RCT, not an open-label study. The dose used (12g/day) is higher than the typical PCOS dose (4g/day), but both are well within the established safety range.
OCD
A 1996 double-blind crossover trial by the same group found that 18g/day myo-inositol significantly reduced OCD symptoms on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) compared to placebo. The improvement was clinically meaningful, though smaller than pharmaceutical interventions. Researchers have proposed that OCD, like panic disorder, may involve relative depletion of inositol in brain regions governing behavioral inhibition, and that supplementation partially corrects this deficit.
Depression
A double-blind RCT published in the American Journal of Psychiatry found that 12g/day myo-inositol produced significant antidepressant effects comparable to placebo control over 4 weeks. While findings in depression are more mixed than in panic disorder and OCD — some trials failed to replicate the effect in treatment-resistant depression — the neurological plausibility and the positive trials warrant attention, particularly for individuals whose depression has an anxiety-predominant profile.
Anxiety and Sleep (with Melatonin)
Emerging research has explored combinations of myo-inositol with melatonin for anxiety-related sleep disturbance. A 2017 observational study found that myo-inositol combined with melatonin significantly reduced sleep onset latency and nighttime awakening in women with PCOS-related sleep disturbances. The proposed mechanism involves myo-inositol's serotonin-system modulation (serotonin being melatonin's biosynthetic precursor) creating synergistic effects on sleep architecture.
Myo-Inositol vs. D-Chiro-Inositol: Which Should You Take?
The choice between myo-inositol (MI) and D-chiro-inositol (DCI) — or a combination product — depends critically on your goals and the specific physiology involved.
| Form | Primary Role | Best For | Typical Dose |
|---|---|---|---|
| Myo-Inositol (MI) | Insulin signaling, neurotransmitter modulation, ovarian follicle quality | Anxiety, panic, OCD, general PCOS support, sleep | 2–4g/day (metabolic); 12–18g/day (neurological) |
| D-Chiro-Inositol (DCI) | Peripheral insulin second messenger; androgen suppression | Peripheral insulin resistance, testosterone reduction | 600mg–1g/day (alone) |
| MI + DCI (40:1 ratio) | Physiological plasma ratio; preserves ovarian FSH sensitivity | PCOS, fertility, IVF support, hormonal balance | 2g MI + 50mg DCI twice daily (Ovasitol dose) |
For neurological applications — anxiety, panic disorder, OCD, or mood support — myo-inositol alone at higher doses (12–18g/day) is the clinically studied form. For PCOS specifically, the 40:1 ratio combination product is currently the evidence-preferred choice. For general insulin resistance or metabolic syndrome without PCOS, myo-inositol alone at 4g/day has the strongest clinical backing. Using DCI alone or in high ratios relative to myo-inositol is now generally discouraged by reproductive specialists due to its potential to impair ovarian function.
Dosing, Forms, and Practical Use
Myo-inositol is available primarily as a powder (which dissolves easily in water or juice) and as capsules. The powder form is often more economical and allows for flexible dosing.
- PCOS and hormonal health: 4g/day total myo-inositol (alone or as part of a 40:1 combination), typically divided as 2g with breakfast and 2g with dinner. Combined with 400mcg folic acid in most clinical protocols. Allow 3–6 months to assess full effect on menstrual regularity and hormonal markers.
- Insulin resistance and metabolic syndrome: 4g/day myo-inositol, split into two 2g doses with meals.
- Anxiety and panic disorder: 12g/day, typically as powder dissolved in water, split across 2–3 doses. This higher dose range was used in the psychiatric clinical trials. Note: at this dose, the powder form is far more practical than capsules.
- OCD: Up to 18g/day under clinical guidance — this is a high dose that requires gradual titration and physician oversight.
- Sleep support (with melatonin): 4g myo-inositol before bed, combined with 0.5–1mg melatonin.
With meals or without? Taking myo-inositol with food improves tolerability and aligns with the metabolic signaling context — insulin is released after meals, and myo-inositol supports post-meal insulin signaling. For neurological effects, timing is more flexible.
Side effects: Myo-inositol has an excellent safety profile. The most common adverse effects at standard doses are mild GI upset, bloating, and loose stools — particularly at doses above 4g/day. These effects typically diminish after 1–2 weeks as the body adapts. At the very high doses used for OCD (18g/day), GI side effects are more pronounced. No serious safety signals have emerged in clinical trials.
Best Myo-Inositol Supplements on Amazon (2026)
1. Ovasitol (Theralogix) Myo-Inositol + D-Chiro-Inositol
Best Overall / PCOS
Ovasitol is the gold standard for PCOS supplementation, developed directly from the clinical research on the 40:1 myo-inositol to D-chiro-inositol ratio. Each serving delivers 2,000mg myo-inositol and 50mg D-chiro-inositol — the physiological plasma ratio. Theralogix, the manufacturer, is a nutraceutical company founded by researchers at Johns Hopkins and was one of the first companies to bring evidence-based inositol ratios to market. The product is NSF Contents Certified, meaning the label claims have been third-party verified.
Pros: Clinically validated 40:1 ratio, NSF Contents Certified, recommended by reproductive endocrinologists and OB-GYNs, includes folic acid, powder form for easy dosing, high brand credibility.
Cons: Premium price; requires twice-daily dosing (the full clinical dose is two sachets per day); predominantly targeted at PCOS/fertility rather than general metabolic or neurological use.
Best for: Women with PCOS, those pursuing fertility support, or anyone who wants the most rigorously evidenced myo-inositol formulation available.
2. Wholesome Story Myo-Inositol 2000mg
Best Value Pure Myo
Wholesome Story offers a clean, high-dose myo-inositol powder that delivers 2,000mg per serving with no unnecessary additives. For those who want pure myo-inositol without the DCI component — either because they are using it for neurological purposes (anxiety, mood) or prefer to manage their inositol ratio separately — this is one of the best value options available. Two scoops reaches the standard 4g PCOS dose. The powder format makes it easy to scale doses for higher neurological applications.
Pros: Pure myo-inositol, no fillers, excellent value per gram, unflavored powder mixes easily, flexible dosing.
Cons: No DCI (appropriate for some uses but not the optimal PCOS formulation); not NSF certified; no additional cofactors like folic acid included.
Best for: Those using myo-inositol primarily for anxiety, mood, or sleep support; individuals who prefer to manage their own MI:DCI ratio; budget-conscious buyers.
3. Fairhaven Health FH Pro for Women (with Myo-Inositol)
Best Fertility Blend
FH Pro for Women is a comprehensive fertility supplement that includes myo-inositol (600mg per serving, with a recommended dose of 4 capsules delivering 2,400mg) alongside CoQ10, NAC, alpha-lipoic acid, melatonin, and a full prenatal vitamin profile. For women pursuing fertility optimization — particularly those with PCOS — this all-in-one approach addresses multiple evidence-based pathways simultaneously: inositol for insulin sensitivity and oocyte quality, CoQ10 for mitochondrial function in eggs, and NAC as an antioxidant for ovarian environment quality. Fairhaven Health is a reproductive health-focused brand with a strong clinical advisory foundation.
Pros: Comprehensive fertility formula, includes inositol plus CoQ10, NAC, and melatonin, prenatal vitamin integration, reputable fertility-specialist brand.
Cons: Myo-inositol dose per serving is lower than standalone products (you'd need multiple servings for 4g/day); more expensive than pure inositol; not the 40:1 ratio formulation.
Best for: Women actively trying to conceive who want a single supplement covering multiple fertility-relevant pathways; PCOS patients preparing for IVF.
4. NOW Foods Inositol 500mg Capsules
Best Budget Option
NOW Foods is one of the most trusted supplement brands for quality-to-value ratio, with decades of manufacturing excellence and robust third-party testing. Their 500mg inositol capsules are a reliable, budget-friendly entry point for those starting myo-inositol or those using it at lower doses for general metabolic support. At the 4g/day therapeutic dose you'd need 8 capsules — manageable, but the powder form becomes more economical at higher doses. NOW Foods products are manufactured in GMP-certified facilities and undergo rigorous in-house and third-party testing.
Pros: Trusted brand with excellent QC, affordable, GMP certified, widely available, capsule form convenient for lower doses.
Cons: Capsule form is less economical than powder at higher therapeutic doses; 500mg per capsule requires multiple capsules to reach clinical doses; plain myo-inositol without cofactors.
Best for: Those new to inositol supplementation, individuals using lower doses (1–2g/day) for general wellness, or those who strongly prefer capsules over powder.
Is Myo-Inositol Safe? Side Effects and Contraindications
Myo-inositol has one of the strongest safety profiles of any supplement with serious clinical evidence. It is naturally present in food, produced endogenously, and the body has well-established mechanisms for metabolizing and excreting excess. Key safety considerations:
- GI effects: The most common side effect at doses above 4g/day is loose stools, bloating, and mild nausea. These are dose-dependent and typically transient. Gradual dose titration significantly reduces GI side effects — start at 1–2g/day and increase over 1–2 weeks.
- Pregnancy: Myo-inositol is generally considered safe in pregnancy at the doses used in gestational diabetes trials (4g/day) and may actually be beneficial. However, always consult your OB-GYN before supplementing during pregnancy.
- Bipolar disorder: Inositol's modulation of the phosphoinositide second messenger system may theoretically interact with lithium (which works partly by depleting inositol). High-dose inositol supplementation in bipolar disorder has not been adequately studied and should be approached with caution and physician supervision.
- Drug interactions: No significant pharmacokinetic drug interactions have been documented for myo-inositol at standard doses. It is generally well-combined with metformin (which is also used in PCOS), and some clinicians use both together.
- Blood glucose: Because myo-inositol improves insulin sensitivity, people taking insulin or insulin secretagogues should monitor glucose levels when starting supplementation — though clinically significant hypoglycemia from myo-inositol alone has not been reported.
Clinical trials lasting up to 6 months at 4g/day, and up to several weeks at 12g/day for neurological indications, have found no serious adverse effects. Myo-inositol is non-toxic and non-habit-forming.
Disclaimer: VitalGuide participates in the Amazon Associates program. Links to Amazon products on this page are affiliate links — we may earn a commission if you purchase through them, at no extra cost to you. This article is for educational purposes only and should not be construed as medical advice. Consult your healthcare provider before starting any new supplement regimen, especially if you have a pre-existing health condition, are pregnant, or take medications.
Frequently Asked Questions
What is myo-inositol used for?
Myo-inositol is primarily used for PCOS (polycystic ovary syndrome), insulin resistance, fertility support, and neurological applications including anxiety, panic disorder, and OCD. It acts as a second messenger precursor in insulin signaling and as a component of the phosphatidylinositol cycle in the brain, giving it both metabolic and neurological activity. It is one of the most clinically studied supplements for PCOS, with dozens of randomized controlled trials supporting its use for restoring ovulation, reducing androgens, improving insulin sensitivity, and supporting oocyte quality.
What is the best dose of myo-inositol for PCOS?
The most widely studied and clinically recommended dose for PCOS is 4g/day of myo-inositol, typically combined with 400mcg folic acid and — for the most evidence-supported formulation — combined with D-chiro-inositol in a 40:1 ratio (2g MI twice daily with 50mg DCI each time). This dose has been validated in multiple randomized controlled trials for improving ovulatory function, reducing testosterone, normalizing LH:FSH ratio, and improving insulin sensitivity. Give the protocol at least 3 months before assessing response, as menstrual cycle normalization typically becomes apparent by 2–4 cycles.
What is the difference between myo-inositol and D-chiro-inositol?
Myo-inositol (MI) and D-chiro-inositol (DCI) are two different stereoisomers of inositol with distinct physiological roles. Myo-inositol is the predominant form in the body and brain, acting as a precursor for cell membrane phospholipids and as a second messenger in both insulin signaling and neurotransmitter receptor cascades. D-chiro-inositol functions primarily as an insulin second messenger in peripheral tissue metabolism and androgen suppression. Critically, the ratio of these two forms matters enormously in the ovary: too much DCI relative to MI in follicular fluid impairs oocyte quality. The physiological plasma ratio (approximately 40:1 MI:DCI) is what the Ovasitol formulation is designed to replicate.
Can myo-inositol help with anxiety?
Yes — clinical evidence specifically supports myo-inositol for panic disorder and OCD, with suggestive (though less consistent) evidence for generalized anxiety and depression. The doses used in psychiatric trials are significantly higher than PCOS doses: 12g/day for panic disorder and up to 18g/day for OCD (both as powder dissolved in water). A notable 1995 randomized crossover trial found 12g/day myo-inositol reduced panic attack frequency comparably to fluvoxamine (an SSRI) but with fewer side effects. The mechanism involves myo-inositol's role in the phosphatidylinositol second messenger cycle, which amplifies signals from serotonin and other neurotransmitter receptors.
How long does myo-inositol take to work for PCOS?
Most women with PCOS begin noticing improvements in menstrual regularity within 1–3 menstrual cycles (roughly 1–3 months) of consistent 4g/day supplementation. Hormonal marker improvements (reductions in LH, testosterone, and fasting insulin) are typically measurable within 3 months. Ovulation restoration — the primary endpoint in most trials — is usually documented at the 3-month mark, with continued improvement through 6 months. Fertility-related outcomes (improved egg quality in IVF, improved spontaneous conception rates) may require 3–6 months of preparation. Consistency of daily dosing is essential; skipping doses disrupts the steady-state tissue concentrations needed for effect.
Can men take myo-inositol?
Yes — while the majority of myo-inositol research focuses on women with PCOS, men can benefit from myo-inositol's insulin-sensitizing and neurological effects. Studies in male infertility have found that myo-inositol supplementation improves sperm parameters — particularly sperm motility — by improving mitochondrial function in sperm cells. For men with insulin resistance or metabolic syndrome, 4g/day may improve insulin sensitivity markers. For neurological applications (anxiety, panic disorder, OCD), the same doses used in women apply equally to men. There are no known adverse hormonal effects of myo-inositol in men.
Is myo-inositol the same as vitamin B8?
The "vitamin B8" label is sometimes used for inositol, but it is technically inaccurate. True vitamins are organic compounds the body cannot synthesize and must obtain through diet. Myo-inositol can be synthesized endogenously from glucose, so it does not strictly qualify as a vitamin. However, in conditions like PCOS and insulin resistance, the body's conversion of myo-inositol may be impaired — creating a functional deficiency that responds to supplementation. The "B8" designation appears primarily in informal wellness contexts and marketing; you will not find it in standard biochemistry or nutrition references. The physiologically accurate classification is a carbocyclic polyol and a conditionally essential nutrient in certain metabolic states.
Sources & Key References
- Gerli S, Papaleo E, Ferrari A, Di Renzo GC (2007). Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. European Review for Medical and Pharmacological Sciences, 11(5), 347–354. — Demonstrated significant improvements in menstrual regularity, ovulation rate, and hormonal parameters with 4g/day myo-inositol over 14 weeks.
- Unfer V, Carlomagno G, Dante G, Facchinetti F (2012). Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecological Endocrinology, 28(7), 509–515. — Systematic review confirming consistent improvements in ovulation, hormones, and insulin sensitivity across multiple RCTs.
- Benini V, Perrone G, Unfer V (2016). Myo-inositol plus D-chiro-inositol in 40:1 physiological ratio shows superior effects compared to myo-inositol in a randomized placebo-controlled study. Gynecological Endocrinology, 32(12), 976–980. — Established the clinical superiority of the 40:1 ratio formulation over myo-inositol alone for PCOS outcomes.
- Benjamin J, Levine J, Fux M, Aviv A, Levy D, Belmaker RH (1995). Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. American Journal of Psychiatry, 152(7), 1084–1086. — Landmark trial establishing myo-inositol efficacy (12g/day) for reducing panic attack frequency comparably to fluvoxamine.
- Fux M, Levine J, Aviv A, Belmaker RH (1996). Inositol treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 153(9), 1219–1221. — Double-blind crossover trial demonstrating significant OCD symptom reduction with 18g/day myo-inositol.
- Giordano D, Corrado F, Santamaria A, et al. (2011). Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. Menopause, 18(1), 102–104. — Demonstrated significant improvements in fasting glucose, insulin, and lipid profiles with myo-inositol in metabolic syndrome.